Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin Deficiency
Farooqi, I. Sadaf
Jebb, Susan A.
Langmack, Gill
Lawrence, Elizabeth
Cheetham, Christopher H.
Prentice, Andrew M.
Hughes, Ieuan A.
McCamish, Mark A.
O'Rahilly, Stephen.
From the Departments of Medicine and Clinical Biochemistry (I.S.F., G.L., S.O.) and Paediatrics (I.A.H.), Addenbrooke's Hospital, Cambridge, United Kingdom; the Medical Research Council Dunn Clinical Nutrition Unit, Cambridge, United Kingdom (S.A.J., A.M.P.); Amgen, Thousand Oaks, Calif. (E.L., M.A.M.); and the Department of Paediatrics, Wycombe Hospital, High Wycombe, United Kingdom (C.H.C.). Address reprint requests to Dr. O'Rahilly at the Departments of Medicine and Clinical Biochemistry, Box 157, Addenbrooke's Hospital, Cambridge CB2 2QQ, United Kingdom, or at [email protected].
New England Journal of Medicine 341(12):p 879-884, September 16, 1999.